Ben Ward
Lastest Stories by Ben Ward
The $2 billion deal marks a significant shift in the power semiconductor industry and has set the bar for future collaborations between industry leaders.
Published:
A growing number of savvy investors have turned their attention to the art of capturing dividends.
Published:
Amid a global climate of fervent electrification, China's burgeoning electric vehicle (EV) industry is accelerating at full throttle.
Published:
In the face of global supply chain challenges and pandemic-era complications, the semiconductor industry is demonstrating its resilience.
Published:
The company's fiscal second-quarter results exceeded expectations, propelling the stock against a backdrop of recent volatility.
Published:
The allegations read like the screenplay of a Wall Street thriller.
Published:
Shares of Aurinia Pharmaceuticals rallied following a series of director departures and news of a strategic review of potential sale or merger opportunities.
Published:
The share price of Greenbrier rose following the announcement of its better-than-expected third-quarter earnings.
Published:
The board of MEI Pharma is under fire from prominent shareholders who argue that a proposed merger with Infinity Pharmaceuticals undervalues the firm.Â
Published:
"Our remaining hope for the Mercury turnaround story was a sale of the company, but Mercury was unable to find a buyer" says this analyst.
Published:
Point72 Asset Management has tripled its position in Praxis Precision Medicines, a clinical-stage biopharmaceutical company specializing in central nervous system disorders.
Published:
Is Argus Research a canary in the coal mine for investors in Universal Technical Institute?
Published:
In a sharp rebound after a challenging fiscal year, Smith & Wesson Brands saw its shares soar on Friday.
Published:
Eagle Bulk Shipping made a bold move this week to fend off a potential hostile takeover.Â
Published:
Overstock.com shares saw a sharp increase after confirmation of its successful bid to purchase a portion of bankrupt Bed Bath & Beyond's intellectual property and assets.
Published: